What is Harrow's R&D?

Harrow (HROW) reported R&D of $5.9M in Q1 2026.

How has Harrow's R&D changed year-over-year?

Harrow's R&D increased by 94.8% year-over-year, from $3.03M to $5.9M.

What is the long-term trend for Harrow's R&D?

Over 4 years (2021 to 2025), Harrow's R&D has grown at a 17.2% compound annual growth rate (CAGR), from $11.08M to $20.94M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Harrow HROW R&D

R&D at other companies

Bausch + LombBLCO

$101M+17.4%

Ocular TherapeutixOCUL

$66.21M+54.5%

ViatrisVTRS

$248.6M+12.0%

Bausch Health CompaniesBHC

$163M+14.0%

Tarsus Pharmaceuticals, Inc.TARS

$22.35M+55.1%

Kodiak Sciences IncKOD

$48.55M+11.2%

Segments

By segment

See full

Branded$5.62M+182%

Compounding$210K-6.3%

Other financials

Income statement

See full

Revenue$44.2M-7.6%

Gross profit$27.0M-16.3%

Operating income-$22.1M-96.6%

Net income-$27.6M-55.2%

EPS (diluted)-$0.74-48.0%

Balance sheet

See full

Cash & equivalents$94.6M+41.8%

Total debt$308.6M-32.9%

Total equity$28.7M-49.1%

Total assets$419.5M+15.2%

Cash flow

See full

Operating cash flow-$9.0M-146%

CapEx$194.0K+14.1%

Free cash flow-$9.2M-147%

Valuation

See full

Market cap$1.59B+38.4%

Enterprise value$1.81B+13.8%

P/S5.9×+0.5×

Profitability

See full

Gross margin74.1%-0.4pp

Operating margin7.3%+5.2pp

Net margin-19.8%+18.0pp

FCF margin5.7%+5.0pp

Returns & leverage

See full

Return on equity-50%+17.5pp

Debt / equity10.7×+2.6×

Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Harrow's R&D?: Harrow (HROW) reported R&D of $5.9M in Q1 2026.
How has Harrow's R&D changed year-over-year?: Harrow's R&D increased by 94.8% year-over-year, from $3.03M to $5.9M.
What is the long-term trend for Harrow's R&D?: Over 4 years (2021 to 2025), Harrow's R&D has grown at a 17.2% compound annual growth rate (CAGR), from $11.08M to $20.94M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.